IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH)

CUSIP: 23254X201

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Class A common stock, $0.001 par value
Shares outstanding
162,474,849
Total 13F shares
480,977
Share change
+24,621
Total reported value
$682,748
Price per share
$1.42
Number of holders
17
Value change
+$31,999
Number of buys
8
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 23254X201?
CUSIP 23254X201 identifies CYTH - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q3 2023

As of 30 Sep 2023, IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 480,977 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, XTX Topco Ltd, Virtu Financial LLC, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, and Royal Bank of Canada. This page lists 17 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.